3 withdrawn. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 3 |
| Phase 1 | 2 | Withdrawn 2 |
Follow Recurrent Marginal Zone Lymphoma: new trials by email Literature Review of Recurrent Marginal Zone Lymphoma trials Research Report on Recurrent Marginal Zone Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma rituximab, lenalidomide, romidepsin - B-cell Adult Acute Lymphoblastic Leukemia, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Phase 1 / Phase 2 | Withdrawn | Mayo Clinic | 2016-10-01 | 2016-08-11 | |
| Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies cyclophosphamide, fludarabine phosphate, mycophenolate mofetil - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Phase 2 | Withdrawn | University of Medicine and Dentistry of New Jersey | 2014-01-01 | 2016-07-14 | |
| Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma bendamustine hydrochloride, obatoclax mesylate, rituximab - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma | Phase 1 / Phase 2 | Withdrawn | National Cancer Institute (NCI) | 2010-10-01 | 2013-06-06 |
Lymphoma, B-Cell, Marginal Zone (3) · Lymphoma, Follicular (3) · Lymphoma, Mantle-Cell (3) · Burkitt Lymphoma (2) · Intraocular Lymphoma (2) · Leukemia, Hairy Cell (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Large-Cell, Immunoblastic (2) · Lymphoma, Non-Hodgkin (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Waldenstrom Macroglobulinemia (2) · Blast Crisis (1) · Congenital Abnormalities (1) · Hodgkin Disease (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma (3) · Lymphoma, B-Cell (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Blood Protein Disorders (2) · Cardiovascular Diseases (2) · Chronic Disease (2) · DNA Virus Infections (2) · Disease Attributes (2) · Epstein-Barr Virus Infections (2)
Rituximab (2) · Bendamustine Hydrochloride (1) · Cord Blood Stem Cell Transplantation (1) · Cyclophosphamide (1) · Lenalidomide (1) · Mycophenolic Acid (1) · Peripheral Blood Stem Cell Transplantation (1) · Tacrolimus (1) · Transplantation (1) · Whole-Body Irradiation (1) · fludarabine phosphate (1) · obatoclax (1) · romidepsin (1)
Mayo Clinic (1) · National Cancer Institute (NCI) (1) · University of Medicine and Dentistry of New Jersey (1)
United States (2)
Elizabeth Christian (1) · Grzegorz Nowakowski (1) · Roger Strair (1)
P30CA015083 (1), P30CA072720 (1), U01CA076576 (1)